A Phase II Study to Evaluate the Efficacy of IdeS to Desensitize Transplant Patients With a Positive Crossmatch Test
Clinical trial NCT02790437 · COMPLETED
Trial details
- NCT number
- NCT02790437
- Sponsor
- Hansa Biopharma AB
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-06-01
- Primary completion
- 2017-12-12
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.